Advert - Strides Pharma
Promotion of Strivit D3 on LinkedIn
-
Date posted12 March 2021
-
SanctionAdvertisement,
-
Case number/s
For promoting Strivit D3 (colecalciferol) on LinkedIn, Strides Pharma was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards
Clause 26.1 - Advertising a prescription only medicine to the public.